Ghias Babar
SEC CIK 2076862 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BCRX | BIOCRYST PHARMACEUTICALS INC | CFO, Head of Corp Development | 268.7K | — | — | 2 | 2025-07-24 | 2025-12-17 |
Most active insiders at BCRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Barnes Alane P | CLO | — | $3.46M |
| 2 | HEGGIE THERESA | Dir | — | $504.8K |
| 3 | McKee Amy E | Dir | — | $100.3K |
| 4 | SANDERS MACHELLE | Dir | — | $68.5K |
| 5 | Menon Sandeep | Chief R, D Off | — | — |
| 6 | Ghias Babar | CFO | — | — |
| 7 | Gayer Charles K | Pres, CCO | — | — |
| 8 | Milne Jill C. | Dir | — | — |
| 9 | Frank Steven | Dir | — | — |
| 10 | Galson Steven K | Dir | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-19 | 2025-12-17 | BCRX | BIOCRYST PHARMACEUTICALS INC | Ghias Babar | CFO | A - Grant | $0.00 | +121.7K | 268.7K | +83% | $0 |
| D | 2025-07-28 | 2025-07-24 | BCRX | BIOCRYST PHARMACEUTICALS INC | Ghias Babar | CFO, Head of Corp Development | A - Grant | $0.00 | +147.0K | 147.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations